This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bell, D. W. Articles by Haber, D. A. Search for Related Content PubMed PubMed Citation Articles by Bell, D. W. Articles by Haber, D. A.

Common Nonsense Mutations in RAD52¹

Center for Cancer Risk Analysis, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts 02129 [D. W. B., D. C. R. W., D. H. K., M. S. M., M. G. F., K. J. I., M. K., D. A. H.]; and Tohoku University, Sendai 980, Japan [C. I.]

RAD51, RAD52, and RAD54 encode proteins that are critical to the repair of double-strand DNA breaks by homologous recombination. The physical interactions among the products of RAD51, BRCA1, and BRCA2 have suggested that the BRCA1 and BRCA2 breast cancer susceptibility genes may function, at least in part, in this DNA damage repair pathway. Given the observation that different genes within a common functional pathway may be targeted by mutations in human cancers, we analyzed RAD51, RAD52, and RAD54 for the presence of germ-line mutations in 100 cases with early-onset breast cancer and for somatic mutations in 15 human breast cancer cell lines. Two premature stop codons, Ser346ter and Tyr415ter, were identified in germ-line RAD52 alleles from 5% of early-onset breast cancer cases. Together, these two heterozygous mutations were also found in 8% of a healthy control population, indicating that they do not confer an increased risk for breast cancer. A rare germ-line missense mutation was identified in RAD54, whereas no sequence variants were found in RAD51. None of the three RAD genes demonstrated somatic mutations in breast cancer cell lines. We conclude that, despite their potential functional association with the BRCA gene products, RAD51, RAD52, and RAD54 are not themselves targeted by mutations in human breast cancer. The presence of common nonsense mutations in RAD52 within the population may have significance for other conditions associated with potential alterations in DNA damage repair pathways.

This article has been cited by other articles:

				H. W. Mohrenweiser, T. Xi, J. Vazquez-Matias, and I. M. Jones Identification of 127Amino Acid Substitution Variants in Screening 37 DNA Repair Genes in Humans Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 1054 - 1064. [Abstract] [Full Text] [PDF]

				J. Han, S. E. Hankinson, I. De Vivo, G. A. Colditz, and D. J. Hunter No Association between a Stop Codon Polymorphism in RAD52 and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 1138 - 1139. [Full Text] [PDF]

				E. Raderschall, K. Stout, S. Freier, V. Suckow, S. Schweiger, and T. Haaf Elevated Levels of Rad51 Recombination Protein in Tumor Cells Cancer Res., January 1, 2002; 62(1): 219 - 225. [Abstract] [Full Text] [PDF]

				W. W. Wang, A. B. Spurdle, P. Kolachana, B. Bove, B. Modan, S. M. Ebbers, G. Suthers, M. A. Tucker, D. J. Kaufman, M. M. Doody, et al. A Single Nucleotide Polymorphism in the 5' Untranslated Region of RAD51 and Risk of Cancer among BRCA1/2 Mutation Carriers Cancer Epidemiol. Biomarkers Prev., September 1, 2001; 10(9): 955 - 960. [Abstract] [Full Text] [PDF]

				J. J. Hu, T. R. Smith, M. S. Miller, H. W. Mohrenweiser, A. Golden, and L.D. Case Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity Carcinogenesis, June 1, 2001; 22(6): 917 - 922. [Abstract] [Full Text] [PDF]